USA |NASDAQ |USD |ADR
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Jul 29, 2022 (est) | Jun 30, 2022 | - | $0.95 | $0.45 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Jul 29, 2022 (est) | Jun 30, 2022 | - | $11.39B | $8.22B |
Astrazeneca Plc's next estimated earnings date (based on same quarter last year's date) is Jul 29, 2022 for the fiscal quarter ending Jun 30, 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 1 | $0.80 | $0.80 | $0.80 |
| Sep 2022 | 1 | $0.80 | $0.80 | $0.80 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 2 | $3.32 | $3.26 | $3.38 |
| Dec 2023 | 3 | $5.12 | $3.75 | $7.60 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 0 / 0 | $0.83 | $0.83 | $0.00 |
| Sep 2022 | 0 / 1 | $0.87 | $0.87 | $0.00 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 2 / 0 | $4.43 | $3.21 | $3.90 |
| Dec 2023 | 1 / 1 | $5.12 | $3.81 | $3.90 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 3 | $10.73B | $10.58B | $10.94B |
| Sep 2022 | 3 | $10.71B | $10.27B | $10.97B |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $43.79B | $42.80B | $44.33B |
| Dec 2023 | 4 | $45.88B | $44.68B | $46.85B |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Apr 29, 2022 | Mar 2022 | $0.83 | $0.95 | 14.46% |
| Feb 10, 2022 | Dec 2021 | $0.73 | $0.84 | 15.07% |
| Nov 12, 2021 | Sep 2021 | $0.91 | $0.54 | -40.88% |
| Jul 29, 2021 | Jun 2021 | $0.69 | $0.45 | -34.38% |
| Apr 30, 2021 | Mar 2021 | $0.96 | $0.82 | -15.29% |
| Feb 11, 2021 | Dec 2020 | $0.68 | $0.54 | -20.59% |
| Nov 5, 2020 | Sep 2020 | $0.44 | $0.47 | 6.82% |
| Jul 30, 2020 | Jun 2020 | $0.40 | $0.48 | 19.37% |
| Apr 29, 2020 | Mar 2020 | $0.49 | $0.53 | 7.80% |
| Feb 14, 2020 | Dec 2019 | $0.56 | $0.45 | -20.76% |
| Oct 24, 2019 | Sep 2019 | $0.41 | $0.50 | 20.00% |
| Jul 25, 2019 | Jun 2019 | $0.31 | $0.37 | 19.36% |
| Apr 26, 2019 | Mar 2019 | $0.38 | $0.45 | 17.91% |
| Feb 14, 2019 | Dec 2018 | $0.89 | $0.79 | -11.31% |
| Nov 8, 2018 | Sep 2018 | $0.37 | $0.36 | -3.64% |
| Jul 26, 2018 | Jun 2018 | $0.30 | $0.35 | 15.23% |
| May 18, 2018 | Mar 2018 | $0.32 | $0.24 | -25.00% |
| Feb 2, 2018 | Dec 2017 | $0.56 | $0.65 | 16.95% |
| Nov 9, 2017 | Sep 2017 | $0.57 | $0.56 | -2.20% |
| Jul 27, 2017 | Jun 2017 | $0.42 | $0.44 | 3.20% |
| Apr 27, 2017 | Mar 2017 | $0.54 | $0.50 | -7.82% |
| Feb 2, 2017 | Dec 2016 | $0.55 | $0.61 | 9.64% |
| Nov 10, 2016 | Sep 2016 | $0.47 | $0.66 | 41.69% |
| Jul 28, 2016 | Jun 2016 | $0.44 | $0.42 | -3.56% |
| Apr 29, 2016 | Mar 2016 | $0.48 | $0.48 | -0.90% |
| Feb 4, 2016 | Dec 2015 | $0.44 | $0.47 | 6.82% |
| Nov 5, 2015 | Sep 2015 | $0.77 | $0.52 | -32.47% |
| Jul 30, 2015 | Jun 2015 | $0.51 | $0.60 | 17.65% |
| Apr 24, 2015 | Mar 2015 | $0.53 | $0.54 | 1.89% |
| Feb 5, 2015 | Dec 2014 | $0.43 | $0.38 | -11.63% |
| Nov 6, 2014 | Sep 2014 | $0.52 | $0.53 | 1.92% |
| Jul 31, 2014 | Jun 2014 | $0.55 | $0.65 | 18.18% |
| Apr 24, 2014 | Mar 2014 | $0.62 | $0.59 | -4.84% |
| Feb 6, 2014 | Dec 2013 | $0.61 | $0.62 | 1.64% |
| Oct 31, 2013 | Sep 2013 | $0.63 | $0.61 | -3.17% |
| Aug 1, 2013 | Jun 2013 | $0.58 | $0.60 | 3.45% |
| Apr 25, 2013 | Mar 2013 | $0.67 | $0.71 | 5.97% |
| Jan 31, 2013 | Dec 2012 | $0.70 | $0.78 | 11.43% |
| Oct 25, 2012 | Sep 2012 | $0.74 | $0.76 | 2.70% |
| Jul 26, 2012 | Jun 2012 | $0.68 | $0.77 | 13.24% |
| Apr 26, 2012 | Mar 2012 | $0.89 | $0.91 | 2.25% |
| Feb 6, 2012 | Dec 2011 | $0.78 | $0.81 | 3.85% |
| Oct 27, 2011 | Sep 2011 | $0.84 | $0.86 | 2.38% |
| Jul 28, 2011 | Jun 2011 | $0.91 | $0.87 | -4.40% |
| Apr 28, 2011 | Mar 2011 | $1.08 | $1.12 | 3.70% |
| Jan 27, 2011 | Dec 2010 | $0.67 | $0.70 | 4.48% |
| Oct 28, 2010 | Sep 2010 | $0.75 | $0.75 | - |
| Jul 29, 2010 | Jun 2010 | $0.80 | $0.90 | 12.50% |
| Apr 29, 2010 | Mar 2010 | $0.86 | $1.01 | 17.44% |
| Jan 28, 2010 | Dec 2009 | $0.76 | $0.71 | -6.58% |
| Oct 29, 2009 | Sep 2009 | $0.69 | $0.84 | 21.74% |
| Jul 30, 2009 | Jun 2009 | $0.70 | $0.82 | 17.14% |
| Apr 30, 2009 | Mar 2009 | $0.70 | $0.79 | 12.86% |
| Jan 29, 2009 | Dec 2008 | $0.58 | $0.63 | 8.62% |
| Oct 30, 2008 | Sep 2008 | $0.57 | $0.66 | 15.79% |
| Jul 31, 2008 | Jun 2008 | $0.54 | $0.63 | 16.67% |
| Apr 24, 2008 | Mar 2008 | $0.60 | $0.64 | 6.67% |
| Jan 31, 2008 | Dec 2007 | $0.47 | $0.55 | 17.02% |
| Nov 1, 2007 | Sep 2007 | $0.46 | $0.52 | 13.04% |
| Jul 26, 2007 | Jun 2007 | $0.52 | $0.60 | 15.38% |
| Apr 23, 2007 | Mar 2007 | $0.51 | $0.51 | - |
| Feb 1, 2007 | Dec 2006 | $0.48 | $0.47 | -2.08% |
| Oct 26, 2006 | Sep 2006 | $0.49 | $0.51 | 4.08% |
| Jul 27, 2006 | Jun 2006 | $0.47 | $0.51 | 8.51% |
| Apr 27, 2006 | Mar 2006 | $0.40 | $0.45 | 12.50% |
| Feb 2, 2006 | Dec 2005 | $0.37 | $0.39 | 5.41% |
| Oct 27, 2005 | Sep 2005 | $0.33 | $0.38 | 15.15% |
| Jul 28, 2005 | Jun 2005 | $0.28 | $0.38 | 35.71% |
| Apr 28, 2005 | Mar 2005 | $0.29 | $0.32 | 10.34% |
| Jan 28, 2005 | Dec 2004 | $0.29 | $0.30 | 3.45% |
| Oct 25, 2004 | Sep 2004 | $0.26 | $0.28 | 7.69% |
| Jul 22, 2004 | Jun 2004 | $0.24 | $0.25 | 4.17% |
| Apr 29, 2004 | Mar 2004 | $0.27 | $0.24 | -11.11% |
| Jan 29, 2004 | Dec 2003 | $0.20 | $0.19 | -5.00% |
| Oct 23, 2003 | Sep 2003 | $0.17 | $0.24 | 41.18% |
| Jul 24, 2003 | Jun 2003 | $0.17 | $0.20 | 17.65% |
| Apr 30, 2003 | Mar 2003 | $0.21 | $0.27 | 28.57% |
| Jan 30, 2003 | Dec 2002 | $0.21 | $0.23 | 9.52% |
| Oct 24, 2002 | Sep 2002 | $0.18 | $0.20 | 11.11% |
| Jul 25, 2002 | Jun 2002 | $0.24 | $0.23 | -4.17% |
| Apr 26, 2002 | Mar 2002 | $0.24 | $0.28 | 16.67% |
| Jan 31, 2002 | Dec 2001 | $0.23 | $0.89 | 286.96% |
| Oct 24, 2001 | Sep 2001 | $0.21 | $0.24 | 14.29% |
| Jul 26, 2001 | Jun 2001 | $0.21 | $0.21 | - |
| Mar 31, 2001 | Mar 2001 | - | $0.22 | - |
| Feb 8, 2001 | Dec 2000 | $0.21 | $0.21 | - |
| Oct 25, 2000 | Sep 2000 | $0.23 | $0.19 | -17.39% |
| Oct 29, 1999 | Sep 1999 | $0.17 | $0.19 | 11.76% |
| Feb 17, 1999 | Dec 1998 | $0.24 | $0.25 | 4.17% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 10, 2022 | Dec 2021 | $3.21 | $2.65 | -17.60% |
| Feb 11, 2021 | Dec 2020 | $2.47 | $2.02 | -18.42% |
| Feb 14, 2020 | Dec 2019 | $1.82 | $1.75 | -3.85% |
| Feb 14, 2019 | Dec 2018 | $1.66 | $1.73 | 4.22% |
| Feb 2, 2018 | Dec 2017 | $1.94 | $2.14 | 10.31% |
| Feb 2, 2017 | Dec 2016 | - | $2.16 | - |
| Feb 4, 2016 | Dec 2015 | - | $2.13 | - |
| Feb 5, 2015 | Dec 2014 | - | $2.15 | - |
| Feb 6, 2014 | Dec 2013 | - | $2.54 | - |
| Jan 31, 2013 | Dec 2012 | - | $3.22 | - |
| Feb 6, 2012 | Dec 2011 | - | $3.66 | - |
| Jan 27, 2011 | Dec 2010 | - | $3.36 | - |
| Jan 28, 2010 | Dec 2009 | - | $3.16 | - |
| Jan 29, 2009 | Dec 2008 | - | $2.56 | - |
| Jan 31, 2008 | Dec 2007 | - | $2.18 | - |
| Feb 1, 2007 | Dec 2006 | - | $1.94 | - |
| Feb 2, 2006 | Dec 2005 | - | $1.47 | - |
| Jan 28, 2005 | Dec 2004 | - | $1.07 | - |
| Jan 29, 2004 | Dec 2003 | - | $0.90 | - |
| Jan 30, 2003 | Dec 2002 | - | $0.94 | - |
| Jan 31, 2002 | Dec 2001 | - | $1.56 | - |
| Feb 8, 2001 | Dec 2000 | - | $0.59 | - |
| Feb 17, 1999 | Dec 1998 | - | $0.25 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Apr 29, 2022 | Mar 2022 | $10.99B | $11.39B | 1.04% |
| Feb 10, 2022 | Dec 2021 | $10.96B | $12.01B | 1.10% |
| Nov 12, 2021 | Sep 2021 | $9.87B | $9.87B | 1.00% |
| Jul 29, 2021 | Jun 2021 | $7.59B | $8.22B | 1.08% |
| Apr 30, 2021 | Mar 2021 | $7.08B | $7.32B | 1.03% |
| Feb 11, 2021 | Dec 2020 | $6.97B | $7.41B | 1.06% |
| Nov 5, 2020 | Sep 2020 | $6.65B | $6.58B | 0.99% |
| Jul 30, 2020 | Jun 2020 | $6.24B | $6.28B | 1.01% |
| Apr 29, 2020 | Mar 2020 | $5.90B | $6.28B | 1.06% |
| Feb 14, 2020 | Dec 2019 | $6.75B | $6.66B | 0.99% |
| Oct 24, 2019 | Sep 2019 | $6.18B | $6.41B | 1.04% |
| Jul 25, 2019 | Jun 2019 | $5.51B | $5.82B | 1.06% |
| Apr 26, 2019 | Mar 2019 | $5.42B | $5.49B | 1.01% |
| Feb 14, 2019 | Dec 2018 | $6.27B | $6.42B | 1.02% |
| Nov 8, 2018 | Sep 2018 | $5.49B | $5.34B | 0.97% |
| Jul 26, 2018 | Jun 2018 | $5.09B | $5.16B | 1.01% |
| May 18, 2018 | Mar 2018 | $5.24B | $5.24B | 1.00% |
| Feb 2, 2018 | Dec 2017 | $5.49B | $5.78B | 1.05% |
| Nov 9, 2017 | Sep 2017 | $5.69B | $6.23B | 1.09% |
| Jul 27, 2017 | Jun 2017 | $5.07B | $5.05B | 1.00% |
| Apr 27, 2017 | Mar 2017 | $5.41B | $5.72B | 1.06% |
| Feb 2, 2017 | Dec 2016 | - | $5.58B | - |
| Nov 10, 2016 | Sep 2016 | - | $5.70B | - |
| Jul 28, 2016 | Jun 2016 | - | $5.60B | - |
| Apr 29, 2016 | Mar 2016 | - | $6.17B | - |
| Feb 4, 2016 | Dec 2015 | - | $6.40B | - |
| Nov 5, 2015 | Sep 2015 | - | $5.95B | - |
| Jul 30, 2015 | Jun 2015 | - | $6.31B | - |
| Apr 24, 2015 | Mar 2015 | - | $6.43B | - |
| Feb 5, 2015 | Dec 2014 | - | $6.68B | - |
| Nov 6, 2014 | Sep 2014 | - | $6.54B | - |
| Jul 31, 2014 | Jun 2014 | - | $6.45B | - |
| Apr 24, 2014 | Mar 2014 | - | $6.58B | - |
| Feb 6, 2014 | Dec 2013 | - | $6.84B | - |
| Oct 31, 2013 | Sep 2013 | - | $6.25B | - |
| Aug 1, 2013 | Jun 2013 | - | $6.23B | - |
| Apr 25, 2013 | Mar 2013 | - | $6.52B | - |
| Jan 31, 2013 | Dec 2012 | - | $7.28B | - |
| Oct 25, 2012 | Sep 2012 | - | $6.68B | - |
| Jul 26, 2012 | Jun 2012 | - | $6.66B | - |
| Apr 26, 2012 | Mar 2012 | - | $7.60B | - |
| Feb 6, 2012 | Dec 2011 | - | $8.66B | - |
| Oct 27, 2011 | Sep 2011 | - | $8.21B | - |
| Jul 28, 2011 | Jun 2011 | - | $8.43B | - |
| Apr 28, 2011 | Mar 2011 | - | $8.49B | - |
| Jan 27, 2011 | Dec 2010 | - | $8.62B | - |
| Oct 28, 2010 | Sep 2010 | - | $7.90B | - |
| Jul 29, 2010 | Jun 2010 | - | $8.18B | - |
| Apr 29, 2010 | Mar 2010 | - | $8.83B | - |
| Jan 28, 2010 | Dec 2009 | - | $8.95B | - |
| Oct 29, 2009 | Sep 2009 | - | $8.20B | - |
| Jul 30, 2009 | Jun 2009 | - | $7.96B | - |
| Apr 30, 2009 | Mar 2009 | - | $7.97B | - |
| Jan 29, 2009 | Dec 2008 | - | $8.19B | - |
| Oct 30, 2008 | Sep 2008 | - | $7.78B | - |
| Jul 31, 2008 | Jun 2008 | - | $7.96B | - |
| Apr 24, 2008 | Mar 2008 | - | $7.80B | - |
| Jan 31, 2008 | Dec 2007 | - | $8.17B | - |
| Nov 1, 2007 | Sep 2007 | - | $7.15B | - |
| Jul 26, 2007 | Jun 2007 | - | $7.27B | - |
| Apr 23, 2007 | Mar 2007 | - | $7.10B | - |
| Feb 1, 2007 | Dec 2006 | - | $7.15B | - |
| Oct 26, 2006 | Sep 2006 | - | $6.52B | - |
| Jul 27, 2006 | Jun 2006 | - | $6.62B | - |
| Apr 27, 2006 | Mar 2006 | - | $6.26B | - |
| Feb 2, 2006 | Dec 2005 | - | $6.29B | - |
| Oct 27, 2005 | Sep 2005 | - | $5.79B | - |
| Jul 28, 2005 | Jun 2005 | - | $6.13B | - |
| Apr 28, 2005 | Mar 2005 | - | $5.79B | - |
| Jan 28, 2005 | Dec 2004 | - | $5.80B | - |
| Oct 25, 2004 | Sep 2004 | - | $5.26B | - |
| Jul 22, 2004 | Jun 2004 | - | $5.29B | - |
| Apr 29, 2004 | Mar 2004 | - | $5.12B | - |
| Jan 29, 2004 | Dec 2003 | - | $4.88B | - |
| Oct 23, 2003 | Sep 2003 | - | $4.78B | - |
| Jul 24, 2003 | Jun 2003 | - | $4.45B | - |
| Apr 30, 2003 | Mar 2003 | - | $4.75B | - |
| Jan 30, 2003 | Dec 2002 | - | $4.72B | - |
| Oct 24, 2002 | Sep 2002 | - | $4.27B | - |
| Jul 25, 2002 | Jun 2002 | - | $4.31B | - |
| Apr 26, 2002 | Mar 2002 | - | $4.58B | - |
| Jan 31, 2002 | Dec 2001 | - | $11.51B | - |
| Oct 24, 2001 | Sep 2001 | - | $3.95B | - |
| Jul 26, 2001 | Jun 2001 | - | $4.10B | - |
| Mar 31, 2001 | Mar 2001 | - | $4.15B | - |
| Feb 8, 2001 | Dec 2000 | - | $6.48B | - |
| Oct 25, 2000 | Sep 2000 | - | $3.77B | - |
| Oct 29, 1999 | Sep 1999 | - | $4.28B | - |
| Feb 17, 1999 | Dec 1998 | - | $1.89B | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 10, 2022 | Dec 2021 | $36.27B | $37.42B | 3.17% |
| Feb 11, 2021 | Dec 2020 | $26.24B | $26.62B | 1.42% |
| Feb 14, 2020 | Dec 2019 | $24.42B | $24.38B | -0.14% |
| Feb 14, 2019 | Dec 2018 | $22.03B | $22.09B | 0.29% |
| Feb 2, 2018 | Dec 2017 | $22.11B | $22.46B | 1.60% |
| Feb 2, 2017 | Dec 2016 | - | $23.00B | - |
| Feb 4, 2016 | Dec 2015 | - | $24.71B | - |
| Feb 5, 2015 | Dec 2014 | - | $26.09B | - |
| Feb 6, 2014 | Dec 2013 | - | $25.71B | - |
| Jan 31, 2013 | Dec 2012 | - | $27.97B | - |
| Feb 6, 2012 | Dec 2011 | - | $33.59B | - |
| Jan 27, 2011 | Dec 2010 | - | $33.27B | - |
| Jan 28, 2010 | Dec 2009 | - | $32.80B | - |
| Jan 29, 2009 | Dec 2008 | - | $31.60B | - |
| Jan 31, 2008 | Dec 2007 | - | $29.56B | - |
| Feb 1, 2007 | Dec 2006 | - | $26.48B | - |
| Feb 2, 2006 | Dec 2005 | - | $23.95B | - |
| Jan 28, 2005 | Dec 2004 | - | $21.43B | - |
| Jan 29, 2004 | Dec 2003 | - | $18.85B | - |
| Jan 30, 2003 | Dec 2002 | - | $17.84B | - |
| Jan 31, 2002 | Dec 2001 | - | $23.57B | - |
| Feb 8, 2001 | Dec 2000 | - | $18.12B | - |
| Feb 17, 1999 | Dec 1998 | - | $9.15B | - |
AZN's next estimated earnings date (based on same quarter last year's report date) is Jul 29, 2022 for the fiscal quarter ending Jun 30, 2022.
Astrazeneca Plc's previous earnings date was Apr 29, 2022 for its fiscal quarter ended Mar 31, 2022.
AZN's earnings per share (EPS) was $0.95, beating the consensus analysts forecast of $0.83 by 14.46%.
The EPS was higher than the previous fiscal quarter (Dec 2021) by 13.10%, and higher than the same period a year before (Mar 2021) by 16.56%.
Revenues were $11.39B, better than the forecast of $10.99B by 3.63%, down by -5.17% from the previous quarter , and up by 55.60% from the same period last year.
The company reported a net income of $386.00M.Free cash flow for the quarter was $2.87B , compared to $700.00M last quarter and $1.47B a year before.
AZN ended the quarter with $31.10B in total debt, an increase of 1.03% compared to the previous quarter, and an increase of 54.48% compared to the same quarter a year before.
Astrazeneca Plc's previous annual earnings date was Feb 10, 2022 for its fiscal year ended Dec 31, 2021.
AZN's earnings per share (EPS) was $2.65, missing the consensus analysts forecast of $3.21 by -17.60% , and higher than the previous year's EPS (Dec 2020) by 31.27%.
Revenues were $37.42B, better than the forecast of $36.27B by 3.17%, and up by 40.58% from previous year's revenue.
The company reported a net income of $112.00M, -96.50% lower than the previous year.
Astrazeneca Plc reported a free cash flow of $3.76B for its fiscal year, compared to $2.19B a year ago.
The company ended the fiscal year with $30.78B in total debt, an increase of 54.75% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
